BNP-H Ointment (Canada)

This page contains information on BNP-H Ointment for veterinary use.
The information provided typically includes the following:
  • BNP-H Ointment Indications
  • Warnings and cautions for BNP-H Ointment
  • Direction and dosage information for BNP-H Ointment

Bnp-h Ointment

This treatment applies to the following species:
Manufacturer: Vétoquinol-Vetcom

Ophthalmic Ointment

DIN 00517917

Sterile

Veterinary Use Only

Description: Each Gram Contains

Bacitracin zinc

400 units

Neomycin Sulfate (Equivalent to 3.5 mg of Neomycin Base)

5 mg

Polymyxin B Sulfate

5,000 units

Hydrocortisone Acetate

10 mg

In a base of White Petrolatum and Mineral Oil.

Action

The overlapping spectra of these three antibiotics provide effective bactericidal action against the most commonly occuring gram-positive and gram-negative bacteria associated with infections of the eyes. The range of bactericidal activity encompasses many bacteria which are, or have become, resistant to other antibiotics, notably Pseudomonas and Staphylococcus. In susceptible organisms, resistance rarely develops, even on repeated or prolonged use. Hydrocortisone acetate exerts a marked anti-inflammatory action at the tissue level and effectively suppresses inflammation in many disorders of the anterior segment of the eye. Local application to the eye often gives rapid relief of pain and photophobia, particularly in lesions of the cornea.

The combined anti-inflammatory and antimicrobial activity of Bacitracin-Neomycin-Polymyxin with Hydrocortisone ointment permits effective management of many disorders of the anterior segment of the eye in which this combined activity is needed.

BNP-H Ointment Indications

It may be used in acute or chronic conjunctivitis, when caused by organisms susceptible to the antibiotics contained in this ointment. Laboratory tests should be conducted including in-vitro culturing and susceptibility tests on samples collected prior to treatment.

Contraindications

Ophthalmic preparations containing corticosteroids are contraindicated in the treatment of those deep, ulcerative lesions of the cornea where the inner layer (endothelium) is involved, in fungal infections and in the presence of viral infections.

Warning

All topical ophthalmic preparations containing corticosteroids, with or without an antimicrobial agent, are contraindicated in the initial treatment of corneal ulcers. They should not be used until the infection is under control and corneal regeneration is well under way.

Precautions

Sensitivity to this ophthalmic ointment is rare; however, if reactions occur, discontinue use of the preparation.

The prolonged use of antibiotic-containing preparations may result in the overgrowth of nonsusceptible organisms including fungi. Appropriate measures should be taken if this occurs. If infection does not respond to treatment in two or three days, the diagnosis and therapy should be re-evaluated. Animals under treatment with this product should be observed for the usual signs of corticosteroid overdose which include polydipsia, polyuria and occasionally an increase in weight.

Care should be taken not to contaminate the applicator tip during administration of the preparation.

Adverse Reactions

Itching, burning or inflammation may occur in animals sensitive to the product. Discontinue use in such cases.

BNP-H Ointment Dosage And Administration

Apply a thin film over the cornea three or four times daily. The area to be treated should be properly cleansed prior to use. Foreign bodies, crusted exudate and debris should be carefully removed. Insert the tip of the tube beneath the lower lid and express a small quantity of the ointment into the conjuctival sac in dogs and cats.

Keep Tightly Closed

Keep Out Of Reach Of Children

Store At Room Temperature

NET 3.5 g, Ecopak (12 x 3.5 g).

0592

Nac No.

11730021
VÉTOQUINOL CANADA INC.
Distributed by VÉTOQUINOL CANADA INC.
2000, CHEMIN GEORGES, LAVALTRIE, QC, J5T 3S5
Telephone:   450-586-2252
Order Desk:   800-363-1700
Fax:   450-586-4649
Website:   www.vetoquinol.ca
Email:   info@vetoquinol.ca
Every effort has been made to ensure the accuracy of the BNP-H Ointment information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the Canadian product label or package insert.

Copyright © 2014 North American Compendiums. Updated: 2014-05-28

(web4)